Some Bias Claims Of Ex-Biopharma Execs Sent To Arbitration
By Grace Elletson · March 14, 2023, 1:28 PM EDT
Two biopharmaceutical executives must resolve some of their sex bias and retaliation claims against their ex-employer outside of court, despite a new federal law blocking the arbitration of sexual misconduct claims,...
To view the full article, register now.